AVA Synopsis: The authors began their analysis with a “Status Quo Scenario for smoking rates and health outcomes.” They then estimated cigarettes being replaced by use of e-cigarettes,  and projected mortality and life years lost in each model. The study estimated future cigarette use and mortality outcomes in both the status quo and e-cigarette substitution […]

Read Report

AVA Synopsis: The study examined long-term differences in “exhaled breath measurements and respiratory symptoms” among smokers who were “invited to quit or reduce their cigarette consumption” through the use of vapor products. The authors evaluated fractional nitric oxide concentration (FeNo), exhaled carbon monoxide (eCO) and symptom sources. The study was performed “in a 1-year randomized, […]

Read Report

AVA Synopsis: The authors analyzed patients with COPD that had reported daily use of e-cigarettes “at least two follow-up visits over a 24-month period.” A baseline group of similar patients that reported being regular smokers and did not use e-cigarettes was also identified. The study used the Global Initiative for Chronic Obstructive Lung Disease, requiring […]

Read Report

AVA Synopsis: The authors collected patient data from clinic visits. A baseline clinic visit was established and was the first clinical analysis, which was then preceded with two follow-up clinic visits. The authors identified 18 adult e-cigarette users, all of whom “were former tobacco smokers of about 20 conventional cigarettes/day.” Of the 18 patients, 10 […]

Read Report

AVA Synopsis: The authors examined 31 users of electronic cigarettes and vapor products that were healthy, over 18 years of age and had vaped for more than one and using a nicotine concentration of more than 9 to 12 mg/mL. Participants were asked to use blue eCigs with various flavors. Participants were both sole and […]

Read Report